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KEY TO ABBREVIATIONS 
 FIGO    -    International Federation of Gynaecology and Obstetrics. 
 CT          -    Computed Tomography. 
 MRI        -    Magnetic Resonance Imaging. 
 TRUFI    -    True Fast Imaging with steady state free precession. 
 TSE         -    Turbo Spin Echo. 
 STIR        -    Short Tau Inversion Recovery 
 DWI         -    Diffusion Weighted Imaging 
 ADC        -    Apparent Diffusion Coefficient Maps 
 DTPA      -    Diethylene Triamine Penta Acetic Acid 
 TR            -    Time to Repetition 
 TE            -    Time to Echo 
 FOV        -    Field of View 
 RT            -    Radiotherapy 
 DCE         -    Dynamic Contrast Enhanced 
 FDG- PET -  Fluoro-deoxy-glucose Positron Emission Tomography 
 EBRT        -  External Beam Radiotherapy 
 CIN           -   Cervical Intraepithelial Neoplasia 
 RECIST    -   Response Evaluation Criteria In Solid Tumours 
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INTRODUCTION 
        MR imaging of cervix has evolved over the past two decades as the most 
useful imaging. It is not only useful for preoperative staging but it also helps in 
identification of recurrent / residual tumors in treated patients. 
       Carcinoma cervix is the most common gynaecological cancer in India and 
the second most common cancer worldwide. It predominantly affects 
multiparous women and it is transmitted by human papilloma virus infection.   
2, 88,000 deaths occur annually worldwide due to carcinoma cervix. Incidence 
of carcinoma cervix rises from 30 – 34 years and peaks at 50-55 years. The 
prevalence of cervical carcinoma has increased in recent years due to early 
screening programs. 
       The screening programs prompt the patients to undergo further evaluation. 
MR imaging proves to be the next best level of modality in cervical carcinoma. 
MRI accurately stages the carcinoma which is better than clinical staging. 
  
12 
 
OBJECTIVES OF THE STUDY 
 To evaluate the efficacy of MRI in assessment of important prognostic 
factors in carcinoma cervix like tumor size, involvement of parametrium, 
involvement of pelvic side wall, involvement of adjacent organs and the 
nodal status and how it alters the plan of management . 
 
 To study the role of MRI in detecting the recurrence of carcinoma cervix 
in patients treated with radiotherapy. 
 
 To correlate MRI findings with FIGO staging of carcinoma cervix. 
 
 To evaluate the validity of MRI in detection of treatment response and 
recurrence in treated patients of carcinoma cervix. 
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REVIEW OF LITERATURE 
ANATOMY OF CERVIX: 
       Cervix is a cylindrical structure lying between the uterus and vagina. It 
consists of fibromuscular tissue. Cervix is divided into supravaginal and vaginal 
portions by fornix. Columnar epithelium lines the supravaginal portion and 
squamous epithelium lines the vaginal portion. The squamous cells covering the 
surface of cervix moves upward to cover the columnar cells. This area between 
the tissue squamo columnar junction and the physiologic squamo columnar 
junction forms the transition zone which is the site of development of 
carcinoma. 
MRI ANATOMY OF CERVIX: 
        MRI anatomy is better studied in T2 W images because it gives good soft 
tissue contrast. There are four major zones from the centre to periphery. They 
are 
 High signal intensity endometrial canal forms zone 1. 
 Zone 2 is formed by intermediate signal intensity plicae palmatae. 
 Zone 3 is formed by low signal intensity fibrous stroma. 
 Zone 4 is formed by intermediate signal intensity outer smooth muscle. 
Zone 1 and 2 should measure 2-3 mm together. The fibrous stroma measures 3-
8 mm. 
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TECHNIQUE: 
        MRI was performed with body coil and pelvic phased array coil. The 
images were acquired from the level of lower pole of kidneys to vulva. The 
pelvic phased array coil was used to increase resolution by improving the signal 
–noise ratio and decrease the time required for imaging. [1]. Oblique sagittal 
images were taken parallel to the long axis of cervical canal. The oblique axial 
images were taken perpendicular to the axis of orientation of cervical canal. 
        T2 W axial and coronal images of abdomen were useful in the assessment 
of lymph nodes, distant metastases and hydroureteronephrosis. The T2W 
oblique axial images demonstrated the tumor extension into the parametrium, 
pelvic side walls, ureters, evaluation of rectal and bladder wall and lymph node 
involvement. Sagittal T2 W images were useful for demonstration of the tumor 
relation with uterine body, vagina, bladder and rectum. 
        Diffusion weighed images were useful for assessment of tumor extension, 
parametrial invasion and lymph node involvement. [2]. STIR images helped in 
the identification of peritoneal edema. Dynamic contrast enhanced T1 weighted 
images helped in identification of smaller tumors, adjacent organ invasion and 
fistulous tracts. [3]. DCE images were particularly useful for post radio therapy 
follow up cases. 
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        The anterior saturation band was applied to reduce respiratory and 
peristaltic artifacts. Body coils were particularly useful for obese patients and 
for retroperitoneal evaluation. [4] 
Planes for imaging in MRI 
 
DYNAMIC CONTRAST IMAGING IN CA CERVIX  
        The contrast gadolinium DTPA was given at a dose of 0.1 mmol / kg at a 
rate of 1 ml / second. The tumour myometrium interface was assessed in atleast 
two phases of the following 
 The early enhancement phases (0 and 1minute) to show enhancement of 
subendometrial zone earlier than the bulk of myometrium. 
 The equilibrium phase (2 – 3 minutes after injection) to evaluate deep 
myometrial invasion. [5] 
 The delayed phase (4 – 5 minutes) to evaluate cervical stromal 
invasion.[6] 
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DIFFUSION WEIGHTED IMAGING IN CARCINOMA CERVIX  
        Diffusion weighted imaging in gynaecological malignancies is a newly 
evolving imaging technique based on principles of molecular diffusion. This 
improves the diagnostic accuracy, staging of tumor, prediction of therapy 
response of tumors and post treatment follow up of patient. DWI was found to 
be the most useful in our study that assessed nodal status and tumour recurrence 
[7]. This, when combined with T2W imaging gave good morphological and 
physiologic details of the tumor. 
The information that was gained from diffusion weighted imaging in our study 
included  
  Staging of malignancy  
  Differentiating benign from malignant lesions  
 Assessment of treatment response  
 Early diagnosis of disease recurrence  
        In particular, in cases of carcinoma cervix, DWI was clinically relevant in 
the following scenarios: Isointense tumors, margins of which were difficult to 
define with T2 W images and patients with early cervical cancer in whom 
fertility preserving surgery was planned. 
        DWI was also valuable in response evaluation and detection of tumor 
recurrence. A response in ADC values after 2 weeks of therapy indicated good 
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response. After surgery or radiotherapy, it was difficult to differentiate between 
fibrosis and tumor recurrence. DWI was helpful in this scenario. High ADC 
values represented areas of inflammation and lower ADC values suggested 
tumor recurrence. 
        DWI was also useful in evaluating mesenteric implants, bowel serosal 
deposits and metastatic lesions at other sites. DWI, when used alone provided 
little anatomic information in case of malignancy. Hence, they were used with 
other conventional MRI imaging techniques. DWI used alone resulted in false 
positive findings. This could be considered as an excellent choice of 
investigation in patients with renal function impairment since contrast could not 
be administered in these cases. 
Axial T2 W image showing hyperintense lesion in cervix with disruption of 
cervical stromal ring and parametrial invasion. The tumor showing high 
signal intensity on DWI and low signal intensity on ADC. 
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ROLE OF MRI IN PRETREATEMENT ASSESSMENT OF CANCER 
CERVIX 
        The various modalities used in FIGO (International Federation of 
Gynaecology and Obstetrics) staging system are physical examination, 
cystoscopy, proctoscopy, intravenous urography and x rays. MRI is considered 
superior now due to its ability of soft tissue delineation. In cases with early 
stage disease, it helps in determining the appropriateness of surgery or primary 
chemo radiation.        
In advanced cases, it helps to decide between patients who need surgical 
management and the patients who need chemoradiation in order to avoid 
trimodality therapy with its known complications [8]. In cases with large sized 
tumours, chemoradiation is the preferred treatment. MRI helps to delineate the 
exact pelvic extent of the disease which helps to obviate the need for invasive 
investigations in the patient [9]. The addition of concomitant chemotherapy in 
treatment modality has improved the outcomes with an increase in overall 
survival and progression free survival. However, it also has its own side effects. 
Hence, patients have to be chosen carefully. MRI assists in this purpose.  
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MRI IN EBRT PLANNING  
        Success of the treatment with radiotherapy depends upon several factors 
like accurate delineation of the mass, targeting and delivery of sufficient 
radiation to the entire tumor. The gross target volume is the tumor that is visible 
(clinically or at imaging). The clinical target volume is a larger region that 
encompasses areas at risk for microscopic disease & also MRI facilitates 
accurate volumetric definition of target volume. The planning target volume 
includes the clinical target volume and further variation in the daily setup of 
radiation delivery and also compensates for the patient motion, internal tumor 
motion that may occur due to differential bladder and rectal filling.  
        The cross sectional imaging and three dimensional conformal treatment 
results in improved dose delivery to target tumor while protecting the 
surrounding vital organs like bladder, rectum and large intestine from radiation 
induced damage. [10] Thus, MRI assists in optimization of treatment protocol. 
        Traditionally, pelvic treatment fields are designed according to the bony 
landmarks. However, previous studies have proven that such treatment planning 
has resulted in tumor missing in upto 66 % cases [11]. Therefore, MRI guided 
treatment plan is helpful to cover the tumor volume adequately. 
        Also, large outer and intra fraction mobility of pelvic organs interfere with 
the target volume dose deliverance and dose delivered to the surrounding vital 
organs. Previous studies using MRI have shown that uterus, cervix, vagina and 
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pelvic lymphnodes have significant motion between the treatment due to 
changes in bladder filling, rectal filling and other internal motion. 
MRI IN BRACHYTHERAPY PLANNING  
        MRI for planning of external beam therapy and brachytherapy is still under 
development. Now, the new guidelines and MR imaging facilitate the 
individualized treatment planning for brachytherapy by a process called MR  
image guided adaptive brachytherapy [12] . 
        MRI has transformed the treatment from delivering a uniform dose to point 
A to a targeted therapy to the growth and parametrial invasion. This image 
guided adaptive brachytherapy, according to the studies, improves overall 
survival from 51 – 63 % with conventional MRI to 79 -86 % [13]. MRI guided 
brachytherapy reduces dose to the organs at risk and normal tissues by 12- 32 % 
[14]. For larger tumors and for those in close proximity to vital organs, MRI 
planning of radiotherapy is the gold standard. 
Axial T2 W image shows brachytherapy applicators 
 
 
 
 
 
21 
 
MRI FOR TREATMENT RESPONSE EVALUATION 
        MRI is useful to diagnose the residual tumor early after radiation therapy 
as well as to detect tumor recurrence in post treatment follow up. It is useful in 
the detection of central recurrence in cervix and vagina as well as in 
involvement of parametria and pelvic side walls that are difficult to be assessed 
with clinical examination alone. In these patients, the efficacy of MRI is 
superior to that of PET [15]. 
        During the period of immediate post radiation therapy (within 3 – 8 
weeks), there may be higher false positives due to ongoing inflammatory 
changes. During this period (preferably more than 6 months), DWI is a more 
reliable modality of imaging that increases the identification of recurrence. [16]  
 
Sagittal and axial T2 W images shows stage IIB tumor 
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Sagittal and axial T2 W image in the same patient after treatment shows 
that the cervix is contracted. There is reconstitution of low signal intensity 
of the stroma suggesting a complete response to treatment. 
 
 
 
 
Axial T2 W and dynamic contrast MRI in a patient treated with chemo 
radiotherapy shows no lesion 
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On diffusion weighted image of the same patient, lesion was identified and 
shows diffusion restriction. 
 
Diffusion weighted image of a patient post radiotherapy shows T2 shine 
through effect with no hypointense signal on ADC images. 
 
Sagittal T2 W images show initial tumour seen as hyperintense mass with 
bladder invasion and persistent disease after radiotherapy 
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POST SURGERY APPEARANCE IN MRI 
        Surgery is indicated in patients with early stage disease (upto stage IIA). 
The classic surgery done for this is Wertheim hysterectomy. It consists of total 
abdominal hysterectomy including resection of upper third of vagina, excision 
of parametrial and paravaginal tissue including sacrouterine ligaments and 
dissection of pelvic and para aortic lymph nodes. So after a radical 
hysterectomy, vaginal fornix forms linear soft tissue configuration. A smooth, 
low signal intensity muscular wall on T2 weighted images confirms normal 
appearance. The fibrotic scar tissue in vaginal vault is seen as medium to low 
signal intensity on T2 W images. 
Axial T1 and T2 W images shows linear low signal intensity of vaginal 
fornices in a patient after hysterectomy. 
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Sagittal T2 W image shows low signal 
intensity of muscular layer of vagina and 
high signal intensity of vaginal mucosa. 
 
 
POST RADIATION THERAPY APPEARANCE OF CERVIX IN MRI:  
        The cervix becomes fibrotic and contracted post radiotherapy, with 
reconstitution of normal low signal intensity of the cervix in T2W images. This 
reconstitution of normal cervical anatomy is the best indicator of treatment 
response [17]. Cervix may also show contrast enhancement with gadolinium in 
cases of post radiation fibrosis, post radiation inflammation, necrosis and 
recurrent/ residual tumor. But diffusion weighted imaging is helpful in 
differentiating both. Residual tumor shows diffusion restriction whereas 
inflammatory tissue and fibrosis does not show diffusion restriction. 
        In T2W images, recurrence is seen as a mass with heterogenous 
intermediate to high signal intensity in a background of low signal intensity 
radiation fibrosis. This is particularly useful in cases where imaging is done 6 
months post treatment. Earlier than 6 months, residual tumor and post radiation 
changes can be reliably differentiated using diffusion weighted imaging. [18]. 
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Hricak et al reported that reconstitution of the normal zonal anatomy of cervix 
along with its homogenous low signal intensity have high negative predictive 
value (97%) for recurrence of tumor. [19] 
 
Sagittal T2 W image shows hyperintense cervical mass and post radiation 
image showing reconstitution of normal zonal anatomy of cervix. 
 
 
UTERUS AND OVARIES:  
        Radiation therapy for cervical cancer in premenopausal women can affect 
uterus and ovaries and result in decreased estrogen production. This results in 
changes like atrophy of uterus and ovaries and endometrial thinning. The effect 
on ovaries is dependent on the age of the patient and radiation dosage. 
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Axial T2 W images show normal volume and follicles in both ovaries at 
diagnosis in first image. Second image shows atrophy of both ovaries with 
small number of tiny follicles. 
 
BOWEL:  
        Bowel changes after radiation can be grouped into acute and chronic 
changes. The affected small bowel loops show increased signal intensity in 
T2W images suggesting presence of edema. There is also mural thickening and 
increased signal intensity in perirectal space.  
Axial T2 W image shows thickening of 
rectum and high signal intensity in 
rectal wall. There is also minimal free 
fluid and edema. 
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BLADDER:  
        Acute changes in the bladder in the immediate post radiation period 
includes high signal intensity in bladder wall with mucosal bullous edema in 
T2W images. 
BONE MARROW:   
        Post radiation appearance of pelvic bones include necrosis and replacement 
with fatty marrow. They are sometimes seen as early as 2 weeks after therapy. 
This suggests the highly radiosensitive nature of the hematopoietic elements of 
the bone. They appear as high signal intensity regions in both T1 and T2 
weighted images and are confined to the radiation fields alone.  
Sagittal T2 W image shows fatty replacement of bone marrow included in 
radiation field. There is no residual tumor in cervix. 
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PELVIC SOFT TISSUES:  
        There may be edema of perirectal and presacral spaces and it may show 
linear areas of increased signal in T2 W images.  
CLASSIFICATION OF CERVICAL CARCINOMA USING FIGO 
STAGING SYSTEM: 
FIGO 
STAGING 
 DESCRIPTION 
STAGE I I Carcinoma confined to cervix 
IA Invasive carcinoma identified only microscopically 
IA1 Stromal invasion of greater than 3 mm in depth and no 
wider than 7 mm. 
IA2 Stromal invasion greater than 3mm but less than 5 mm in 
depth and no wider than 7 mm. 
IB1 Clinical lesions no greater than 4 cm 
IB2 Clinical lesions larger than 4 cm 
II II Extension beyond cervix and involvement of upper vagina 
IIA No parametrial invasion 
IIB Parametrial invasion 
III III Invasion of lower third of vagina, invasion to pelvic side 
wall or both 
IIIA Invasion to lower third of vagina 
IIIB Extension to pelvic wall or hydronephrosis or both 
IV IVA Invasion of mucosa of bladder, rectum or bladder and 
rectum, invasion extending beyond the true pelvis or both 
IVB Spread to distant organs 
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CORRELATION BETWEEN FIGO STAGING IN CA CERVIX AND 
THE MRI APPEARANCE: (19) 
STAGE T2 WEIGHTED MRI FINDINGS 
IA No tumor evidence 
IB Tumor hyperintense to hypointense cervical stroma. Tumor 
partially or completely replacing cervical stroma with maintained 
hypointense halo of cervical stroma. 
IIA Segmental interruption of hypointense signal on upper third of 
vaginal wall 
IIB Hyperintense tumor interrupting the hypointense halo of interface 
between cervical stroma and parametrium 
IIIA Segmental interruption of hypointense signal of lower third of 
vagina 
IIIB Tumor extending to musculature (internal obturator, piriformis, 
levator ani) or causing hydroureter. 
IVA Loss of hypointense signal of internal wall (mucosa) of the 
bladder or rectum. 
IVB Distant metastasis 
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Staging of carcinoma cervix: 
 
STAGE I : 
        Stage IA tumors are confined to the cervix. Stage IA tumors are usually not 
visible on MRI. Sometimes, they are seen on dynamic MRI as strongly 
enhancing area on early arterial phase images. [20]. Stage IB tumors appear 
hyperintense on T2W images. MRI is able to assess myometrial invasion and 
relationship of tumor with internal os with a sensitivity of 100% and specificity 
of 96%. [21]. This is useful in younger patients who wish to preserve fertility 
and such patients are treated with trachelectomy. 
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Sagittal T2 W image showing hyperintense 
tumor and intact cervical stroma. Stage IB. 
 
 
 
STAGE II  
        In stage IIA, there is involvement of the upper two thirds of the vagina by 
the tumor, which is seen as segmental disruption of hypointense signal of vagina 
on T2 weighted images. It may also be seen as hyperintense vaginal thickening 
or the mass in contiguity with the vaginal wall. MRI has accuracy of 93% for 
detection of vaginal invasion. The parametrium represents the connective tissue 
between the layers of broad ligament. Medially, it connects the uterus, cervix 
and proximal vagina and laterally, the pelvic wall. It consists of fat and has the 
uterine vessels, nerves and lymphatic vessels traversing through it. 
        Parametrial involvement (stage IIB) is an important prognostic factor 
which influences the therapeutic option. The interface between the normal 
cervical stroma and parametrium appears as a hypointense halo on T2 W 
images. This intact hypointense halo almost rules out parametrial invasion with 
a high negative predictive value. [22]. Segmental disruption or complete 
absence of this hypointense halo and protrusion of tumor into parametrium 
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indicates parametrial invasion. Additional features may include spiculated 
tumour –parametrial interface and encasement of periuterine vessels. Loss of 
parametrial fat may be an indicator of invasion, but is a nonspecific sign since 
peritumoral inflammation in case of large tumors may also simulate the same. 
An important pitfall of MRI staging is over estimation of peritumoral edema as 
parametrial invasion in cases of large cervical tumors.  
Sagittal T2 W image showing slightly 
hyperintense tumor in posterior part of cervix 
extending to upper third of vagina. Stage IIA. 
 
T2 W axial and T1 fat suppressed post contrast axial images showing mass 
in cervix infiltrating into left parametrium. 
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T2 W fat suppressed axial and T1 fat suppressed post contrast axial image 
shows mass in cervix infiltrating into left parametrium 
 
 
T2 W axial image shows endocervical 
mass infiltrating the parametrium 
anteriorly with disruption of 
hypointense cervical stroma. 
 
STAGE III  
        With stage IIIA, there is involvement of lower one third of vagina by the 
tumor. When the tumor extends to pelvic side wall or causes 
hydroureteronephrosis, they are classified as Stage IIIB. The presence of 
hydroureteronephrosis is a specific sign of parametrial invasion. [23] 
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MRI diagnosis of pelvic side wall invasion is made based on following criteria 
[24] 
 Distance between the tumor and pelvic side wall less than 3 mm. 
 Partial / complete loss of normal hypointense signal of pelvic wall 
musculature (piriformis, obturator internus, levator ani, coccygeus 
muscles). 
 Infiltration / encasement of iliac vessels. 
 Bone destruction by diffusely infiltrating tumor. 
 
T2 W fat suppressed axial and T1 fat suppressed post contrast axial image 
shows mass infiltrating into right lateral pelvic wall musculature. 
 
Axial T2 W image shows cervical tumor 
involving urethra extending upto pelvic 
wall with alteration of ischium signal. 
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STAGE IV  
        This stage includes the invasion the adjacent organs (bladder and rectum) 
and distant metastases. The wall of urinary bladder is normally hypointense. 
When the bladder is invaded by the tumor, it shows focal or diffuse areas of 
increased signal intensity on T2 W sequences. Sometimes, the mass may be 
seen protruding into the bladder wall. [25]. It is essential to make sure that both 
the muscular layer and mucosa are involved to label it as bladder invasion. 
Other signs indicative of invasion includes hyperintensity on internal surface of 
posterior wall, nodularity or irregularity in bladder wall. Vesico ureteric 
junction is poorly evaluated using MRI because of poor visualization of non-
dilated ureter with MRI. Some consider the presence of bullous edema to be an 
indirect sign of bladder wall invasion.  
Rectal wall invasion is rare and may appear as focal or segmental loss of 
hypointense signal of the anterior rectal wall [26]. Prominent strands between 
the tumor and the rectal wall may also indicate rectal wall invasion .The 
reported sensitivity of MRI in the evaluation of bladder or rectal wall invasion is 
71- 100% and the specificity corresponds to 88 – 91% [27]. The absence of 
bladder or rectal invasion can be diagnosed with negative predictive value of 
100% so that unnecessary cystoscopy and sigmoidoscopy examinations could 
be avoided.  
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A) T2 W fat suppressed sagittal image shows cervical mass infiltration into 
urinary bladder with discontinuity of inner T2 hypointense bladder 
mucosa. B) T1 axial image shows loss of fat plane between the mass in 
cervix and bladder with focal bladder wall thickening. C) and D) sagittal 
and axial fat suppressed image shows enhancing cervical mass infiltrating 
the bladder 
 
TERMINOLOGIES: 
According to the Response Evaluation Criteria In Solid Tumors (RECIST) 
guidelines, few terminologies are proposed. 
- Refractory disease is defined as residual tumor persisting after 6 months 
of completion of treatment. The tumor here shows intermediate T2 signal, 
restricted diffusion and FDG uptake at PET/CT. 
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- Progressive disease is classified as increase in tumor size by atleast 20% 
from baseline or treatment nadir (smallest diameter). 
- Recurrence is defined as local growth of tumor, presence of distant 
metastases or a combination of both 6 months after completion of 
treatment. 
        Previous studies have shown that one third patients present with recurrence 
approximately within 18 months of therapy. [28].The most common sites of 
recurrence are cervix, parametria, vaginal vault or pelvic side wall. During early 
follow up phase within 6 months, it is difficult to distinguish between post 
radiation change and early tumor recurrence on T2 W image or contrast studies. 
DWI aids in this purpose. 
MRI IN IMAGING OF RECURRENT TUMORS: 
        Recurrent cervical cancer is defined as local tumor regrowth or 
development of nodal or distant metastases after 6 months after the lesion has 
regressed. Two thirds of cases recur within first 2 years following initial 
treatment and 90% of cases recur by 5 years. [29]. Risk factors for recurrence 
include histology of tumor, size, depth of stromal invasion and nodal status at 
presentation. 
        Pelvic recurrence may be located centrally or laterally in pelvis. Extra 
pelvic recurrence commonly involves para-aortic lymphnodes, lungs, liver and 
bone. 
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        MRI is usually done in patients with clinical symptoms suggesting 
possibility of recurrence. There is no definite protocol for follow-up of these 
patients with MRI at regular intervals. MRI is the preferred modality because 
physical examination of irradiated pelvis is limited and cytological examination 
of irradiated cervix has poor sensitivity. [30] 
TUMOR RECURRENCE: 
        Diffusion weighted MRI is useful in the evaluation of irradiated cervix for 
recurrent tumors. Hyperintense signal on high b- value images (b-1000) 
associated with low ADC values suggest presence of recurrent tumor. Weber et 
al found in his study that the most helpful finding for differentiating recurrent 
cervical tumor from radiation fibrosis is the presence of soft tissue mass with 
signal intensity higher than that of pelvic side wall muscle on T2 W images. 
[31]. Hricak et al proposed that the above findings cause a probability of 
recurrence of 86%. [32] 
        With contrast, tumor recurrence exhibits earlier and stronger enhancement 
in comparison with post radiation fibrotic tissue. In addition to the above 
findings, serial MR imaging is also helpful as a tool in differentiating between 
the tumor and post radiation changes. 
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CENTRAL TUMOR RECURRENCE: 
        Patients with central tumor recurrence have a better prognosis than those 
with pelvic side wall recurrence. [33].This is usually situated above vaginal cuff 
between the bladder and rectum. After radical hysterectomy, most tumors show 
supravaginal recurrence at the vaginal stump and in the recto vaginal space. 
Higher incidence of recurrence is observed among patients treated with 
radiotherapy than with surgery. MRI shows high signal intensity in T2WI in 
cases of recurrent tumor similar to primary tumor. There may be associated 
finding of hydrometra due to obstruction to cervical canal.  
        Central pelvic recurrence may cause direct encasement of distal ureter 
resulting in obstruction or infiltration of bladder wall and vesico ureteric 
junction causing obstruction. Imaging findings of bladder invasion include 
nodularity and irregularity of bladder wall, masses protruding into bladder, high 
signal intensity of anterior aspect of posterior bladder wall and abnormal soft 
tissue strands in uterovesical space. [34]. Rectal invasion is shown by mass 
effect, spiculation and luminal narrowing. [35] 
PELVIC SIDEWALL RECURRENCE: 
        It is characterized by direct invasion of mass to the pelvic side wall by a 
linear soft tissue and loss of fat planes or by infiltration of solid mass into the 
muscle of lateral pelvic wall. They manifest as pain due to nerve infiltration or 
leg edema due to obliteration of lymphatics.  
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Central pelvic recurrence of cervical carcinoma. Sagittal T2 W image 
shows heterogenous mass with high signal intensity. There is also bladder 
invasion. With contrast, the mass shows irregular, thick enhancing wall 
and invasion of right pelvic side wall. 
 
LYMPHNODE RECURRENCE: 
        Lymphnodes have been grouped into primary and secondary nodes. 
Primary lymphnodes include paracervical, parametrial, internal and external 
iliac and obturator nodes. Secondary nodes include sacral, common iliac, 
inguinal and para aortic nodes. [36]. Extra pelvic nodes including supra 
clavicular, para aortic and inguinal nodes are common sites of distant 
metastases. Extra pelvic nodal metastasis prevalence is greater in patients 
treated with radiotherapy than surgery due to advanced disease. Diffusion 
Weighted Imaging is useful to differentiate between benign and malignant 
lymphnodes. [37]. 
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DISTANT RECURRENT DISEASE: 
        This include liver, adrenal metastasis and peritoneal deposits. Pulmonary 
manifestations include metastatic lesions, lymphangitic carcinomatosis, 
mediastinal or hilar adenopathy and pleural effusions. Apart from these, osseous 
metastasis is seen occurring in vertebral bodies, pelvis and ribs. 
TREATMENT OPTIONS FOR RECURRENT CARCINOMA CERVIX:  
Primary treatment New imaging finding Suggested new 
treatment 
TAH Local recurrence Irradiation 
Primary lymph node 
recurrence 
Irradiation with 
chemotherapy 
Pelvic irradiation Local recurrence Pelvic exenteration, 
analgesics 
Sacral insufficiency 
fracture 
Analgesics 
Rectovaginal fistula with 
recurrence 
Pelvic exenteration 
TAH or pelvic 
irradiation 
Distant metastasis Chemotherapy or 
conservative therapy 
  
PROGNOSTIC INDICATORS IN STAGING OF CA CERVIX  
        These indicators are not considered for routine FIGO staging but their 
assessment is of prime importance as a prognostic factor. The prognostic 
indicators in the treatment of carcinoma cervix includes the tumor location, size 
of the tumor, parametrial invasion, depth of stromal invasion, extension into the 
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lower uterine cavity and lymphnode involvement. Tumor spread from cervix 
occurs through three different routes. 
o The lateral route, along external iliac vessels. 
o The hypogastric route, along internal iliac vessels. 
o The presacral route, along utero sacral ligament. 
Lymphatic drainage of cervix 
 
 
        All three routes drain finally into the common iliac group of lymph nodes 
from where, they spread to para aortic nodes. The order of involvement of 
lymphnodes is usually paracervical nodes and parametrial nodes, obturator 
nodes, external and internal iliac nodes. In MRI, the sequences of choice for 
visualization of lymphnodes are the T2 W sequences and T2 W TSE fat 
suppressed sequences. DWI images are also useful in the identification of 
metastatic lymphnodes and they appear to show diffusion restriction. 
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The MRI parameters considered for identification of metastatic lymphnodes are 
 Presence of hyperintense areas within nodes on T2 W sequences 
(necrosis) 
 Inhomogenous signal on T2 weighted sequences. 
 Inhomogenous enhancement after gadolinium administration  
 Size of lymph node more than 10 mm  
 Diffusion restriction  in lymphnode  
 
        In T2 weighted sequences, vessels and muscles become hypointense 
whereas the lymphnodes appear slightly T2 hyperintense. FAT SAT sequence 
help in accurate identification of lymphnodes from surrounding fat. Early 
studies demonstrate that a lymphnode with central necrosis identified has 100 % 
positive predictive value for malignancy and is also a poor prognostic factor. 
The use of contrast helps to demonstrate the necrotic nature of the lymphnodes 
easily. Detection of enlarged pelvic lymphnodes on MRI corresponds to usually 
Stage III B whereas, the identified common iliac, inguinal and paraaortic 
lymphnodes correspond to Stage IVB [38]. 
        Patients with lymph node positive disease have decreased survival rates 
[39].  It is important for choice of adjuvant radiation in patients with early 
carcinoma cervix. Surgical lymphnode assessment is the gold standard for 
diagnosis of metastases. Lymphadenectomy carries risk of complications. 
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Hence, preoperative assessment is essential for lymphnodes. Tumor extending 
into the uterine cavity is associated with adverse prognosis in cases of 
carcinoma cervix. It is associated with higher prevalence of distant metastases. 
[40] 
Axial T2 W and axial T2 W fat suppressed images show enlarged 
lymphnodes with hyperintense signal similar to the cervical tumor 
 
COMPLICATIONS FOLLOWING RADIOTHERAPY: 
        Complications can be classified as acute and chronic. The most common 
toxic effects include gastro intestinal symptoms, vulvovaginal  erythema, 
soreness and radiation cystitis. 
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ACUTE AND CHRONIC COMPLICATIONS: 
SITE OR TYPE OF 
COMPLICATION 
ACUTE TOXIC 
EFFECTS 
CHRONIC TOXIC EFFECTS 
Cervix None Cervical stenosis, cervical necrosis 
Gastrointestinal tract Colitis or enteritis Ulceration, stricture formation, 
bowel obstruction 
Urologic Cystitis Fibrotic bladder, hemorrhagic 
cystitis, ureteric stricture 
Fistula formation None Vesicovaginal, rectovaginal, 
rectocervical, uterovaginal, 
enterocervical or enterocutaneous 
fistula 
Skeletal None Insufficiency fractures, 
osteonecrosis, radiation induced 
osteitis, osteomyelitis, radiation 
induced neoplasm 
  
CERVICAL COMPLICATIONS: 
        Cervical stenosis is the most important late complication after radiation 
therapy that usually occurs 9 months after treatment. It is seen as narrowing of 
cervical canal with associated hydro or hematometra. It can be secondary to post 
radiation fibrosis or recurrence of the tumor itself. Cervical necrosis is another 
rare complication seen among smokers. On MRI, cervical necrosis is seen as 
shortening of cervix, intermediate to high T2W signal intensity of cervix and 
gas locules. 
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T2 W image shows cervical stenosis with 
hydrometra in a post radiotherapy patient 
treated for carcinoma cervix. 
 
FISTULA FORMATION: 
        This is a late complication of radiation therapy and now reduced in 
incidence due to development of targeted radiation therapy. The most common 
fistulas are vesicovaginal and enterovaginal fistulas. The reported incidence of 
radiation induced vesicovaginal fistula is 1% to 3%. [41].Post radiation therapy 
fistulas are commonly complex with several tracts. MRI also demonstrates the 
fibrosis and adhesions seen in pelvis. Fistula is seen as a high signal intensity 
fluid filled tract between the organs in T2W images. Sagittal plane is very 
helpful for this. 
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Axial and sagittal T2 W image shows vesicovaginal fistula and tumor 
recurrence in cervix 
 
GASTROINTESTINAL COMPLICATIONS: 
        The incidence of gastrointestinal complication associated with radiation 
therapy is 5%-15%. Usually it occurs at a dose of 45-55 gray of external 
radiation. Chronic radiation injury to bowel is dose dependent and may develop 
several years after treatment. Small bowel is highly radiosensitive and the 
rectum receives the highest dose on account of its fixed position. In MRI, it is 
usually seen as thickening of small bowel with serpentine appearance of bowel 
and associated fat stranding. The commonly involved portion is terminal ileum. 
Chronic fibrosis can cause strictures in bowel and result in obstruction. 
Axial T2 W image shows bowel stricture 
in a patient treated with 
chemoradiotherapy 
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UROLOGIC COMPLICATIONS: 
        Long term effects are dose dependent and are common in patients treated 
with more than 70 Gy of radiation. Acute radiation cystitis was found in upto 
12% patients. [42]. Hemorrhagic cystitis is a late complication. Very few 
patients may develop bladder wall fibrosis that appears on MRI as a thin band 
of low signal intensity in inner aspect of bladder wall. Few patients may 
develop distal ureteric strictures which occurs several months after treatment. 
The most common location for stricture is distal ureter close to vesico ureteric 
junction. 
Axial T2 W image shows high signal 
intensity in bladder wall suggesting wall 
edema and mucosal bullous edema 
 
MUSCULOSKELETAL COMPLICATIONS: 
        The pelvic girdle complications include insufficiency fractures, 
osteonecrosis and osteomyelitis. Bone marrow edema on MRI is seen as high 
signal intensity on T2W and STIR images. Fractures are seen as linear low 
signal intensity region in T1W images. 
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Pelvic insufficiency fracture in a patient 
treated with chemoradiotherapy. 
Coronal STIR image show bilateral 
symmetrical sacral high signal intensity, 
typical of insufficiency fractures. 
RADIATION INDUCED CANCERS: 
        Radiation induced secondary neoplasms may arise from soft tissues or 
bones. But the incidence of this complication is very less (<1%). Previous 
studies have revealed that there is a long term increased risk for colorectal 
carcinoma in patients who underwent pelvic irradiation for carcinoma cervix. 
[43] 
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MATERIALS 
From June 2017 to June 2018, around 70 patients who were histopathologically 
proven cases of carcinoma cervix and referred for MRI pelvis to the Department 
of Radio diagnosis, Coimbatore medical college hospital, Coimbatore were 
included in the study. 
STUDY DESIGN: Hospital based observational study 
SETTING:  
Department of Radio diagnosis in collaboration with Department of Surgical 
oncology, Department of Radiation oncology and Department of Obstetrics and 
Gynaecology. 
STUDY METHODOLOGY: 
Histopathogically diagnosed cases of carcinoma cervix who were referred to the 
Department of Radio diagnosis were included. In this study, two groups of 
patients were included– newly diagnosed and post treatment cases. After 
obtaining permission from the institutional medical research ethics committee 
and taking informed consent from the patients, they were subjected to MRI 
pelvis using a 1.5 – Tesla system. 
Different MRI sequences like TRUFI coronal, axial and sagittal T2WTSE, axial 
and sagittal T1WTSE, STIR axial, DWI – MRI with ADC and contrast 
enhanced oblique axial, coronal and sagittal FST1 WTSE were used. The 
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contrast gadolinium DTPA was given at a dose of 0.1 mmol / kg at a rate of 1 
ml / second. 
MRI 
SEQUENCES 
NON CONTRAST SCANS FAT SUPPRESSED SCANS 
 T1 W FSE T2 W TSE STIR FS T1 W TSE 
(CONTRAST) 
IMAGING 
PLANE 
AXIAL 
AND 
SAGITTAL 
AXIAL 
AND 
SAGITTAL 
AXIAL SAGITTAL AXIAL 
CORONAL 
TR/ TE          
(m sec) 
633/ 11 6320/ 116 9060/14 500/ 11 
FOV  1785*847 1785*847 1785*84
7 
1785*847 
SECTION 
THICKNESS 
(mm) 
4 mm 4 mm 4 mm 5 mm 
MATRIX 768*768 512*512 512*360 768*768 
 
THE FOLLOWING WERE ASSESSED:  
 Size of tumor  
 Tumor enhancement  
 Extension into the vagina and lower uterine body  
 Parametrial / pelvic side wall involvement  
 Urinary bladder / rectal wall invasion  
 Presence of hydroureteronephrosis and distant abdominal metastasis.  
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 Lymph node involvement  
 Complications of radiation therapy 
FIGO staging was incorporated into the MRI grading of the tumor and the 
correlation between the clinical and MRI FIGO staging was studied. In post RT 
patients, tumor recurrence and treatment response were studied. 
INCLUSION CRITERIA:  
 Carcinoma cervix patients who were referred to our department for MR 
imaging both newly diagnosed and those who were on post treatment 
follow up. 
EXCLUSION CRITERIA:  
 Patients with cardiac pacemakers, new implants, clips within the body 
and other contraindications of MR imaging like claustrophobia were 
excluded. 
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RESULTS 
TABLE 1: DISTRIBUTION OF CASES 
CATEGORY NO OF PATIENTS PERCENTAGE 
NEWLY DIAGNOSED 26 37% 
RECURRENT 44 63% 
 
FIGURE 1: 
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TABLE 2: AGE DISTRIBUTION 
 
AGE IN YEARS NO OF PATIENTS PERCENTAGE 
< 40 6 9% 
41-50 27 38% 
51-60 22 31% 
> 60 15 22% 
 
FIGURE 2: 
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TABLE 3: AGE DISTRIBUTION IN RECURRENT AND NEW CASES: 
 
AGE IN YEARS NEW RECURRENT 
< 40 4 2 
41-50 8 19 
51-60 5 17 
> 60 9 6 
 
FIGURE 3: 
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TABLE 4: COMMON PRESENTING SYMPTOMS 
 
SYMPTOMS NO OF PATIENTS PERCENTAGE 
ABDOMINAL PAIN 37 53% 
BLEEDING PV 22 31% 
WHITE DISCHARGE 40 57% 
 
FIGURE 4: 
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TABLE 5: MENSTRUAL STATUS 
 
MENSTRUAL STATUS NO OF PATIENTS PERCENTAGE 
PRE MENOPAUSAL 21 30% 
POST MENOPAUSAL 40 57% 
POST HYSTERECTOMY 9 13% 
 
FIGURE 5: 
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TABLE 6: INTERVAL BETWEEN RT AND IMAGING 
 
DURATION POST RT (N=39) NO OF PATIENTS PERCENTAGE 
< 6 MONTHS 11 28% 
6-12 MONTHS 10 26% 
1-5 YRS 13 33% 
> 5 YRS 5 13% 
 
FIGURE 6: 
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TABLE 7: HYDROURETERONEPHROSIS 
 
HYDROURETERONEPHROSIS NO OF PATIENTS PERCENTAGE 
PRESENT 10 14% 
ABSENT 60 86% 
  
 FIGURE 7: 
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TABLE 8: CORRELATION BETWEEN HYDROMETRA AND PRESENCE 
OF MASS 
 
HYDROMETRA NEW RECURRENT 
PRESENT 14 15 
ABSENT 12 29 
 
FIGURE 8: 
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NEWLY DIAGNOSED CASES 
TABLE 9: CLINICALLY SUSPECTED MASS IN NEW CASES 
NEWLY DIAGNOSED CASES (N=26) 
CLINICALLY SUSPECTED MASS NO OF PATIENTS PERCENTAGE 
PRESENT 23 88% 
ABSENT 3 12% 
 
FIGURE 9: 
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TABLE 10: CORRELATION BETWEEN CLINICALLY SUSPECTED MASS 
AND POSITIVE MRI FINDINGS 
 
CLINICALLY SUSPECTED MASS 
POSITIVE MRI FINDINGS 
PRESENT ABSENT 
PRESENT 22 1 
ABSENT 3 0 
 
FIGURE 10: 
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TABLE 11: CORRELATION BETWEEN CLINICAL AND MRI FIGO 
STAGING 
FIGO STAGING CLINICALLY MRI 
IA 1 0 
IB 1 2 
IIA 3 1 
IIB 10 10 
IIIA 1 0 
IIIB 8 0 
IVA 1 8 
IVB 0 3 
 
FIGURE 11: 
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TABLE 12: CYSTOSCOPY FINDINGS IN NEW CASES 
 
CYSTOSCOPY NO OF PATIENTS PERCENTAGE 
BLADDER INVASION 4 16% 
NORMAL 19 73% 
NOT DONE 3 11% 
 
FIGURE 12: 
 
 
 
 
 
15% 
73% 
12% 
CYSTOSCOPY IN NEW CASES 
BLADDER INVASION
NORMAL
NOT DONE
66 
 
TABLE 13: SIGMOIDOSCOPY FINDINGS IN NEW CASES 
 
SIGMOIDOSCOPY NO OF PATIENTS PERCENTAGE 
GROWTH RECTUM 1 4% 
RECTAL INVASION 1 4% 
SIGMOID DIVERTICULITIS 1 4% 
NORMAL 20 76% 
NOT DONE 3 12% 
 
FIGURE 13: 
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TABLE 14: HISTOPATHOLOGICAL TYPES IN NEW CASES 
 
HISTOPATHOLOGY NO OF PATIENTS PERCENTAGE 
SQUAMOUS CELL CARCINOMA 24 92% 
ADENOCARCINOMA 2 8% 
 
FIGURE 14: 
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TABLE 15: LYMPH NODE INVOLVEMENT IN NEW CASES 
 
LYMPH NODES NO OF PATIENTS PERCENTAGE 
ILIAC 4 16% 
PARAMETRIAL 3 12% 
INGUINAL 0 0% 
OBTURATOR 1 4% 
PARAAORTIC 1 4% 
 
FIGURE 15: 
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TABLE 16: POSITIVE MRI FINDINGS IN DIFFERENT SEQUENCES 
 
 
POSITIVE MRI FINDINGS  NO OF PATIENTS PERCENTAGE 
T2W 24 92% 
DWI 25 96% 
CONTRAST 23 88% 
 
FIGURE 16: 
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TABLE 17: STAGING CORRELATION WITH MRI 
 
MRI STAGING 
TYPE OF CASES 
LOWER 
STAGING CORRELATED 
HIGHER 
STAGING 
NEWLY DIAGNOSED 27% 31% 42% 
 
 
FIGURE 17: 
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RECURRENT CASES 
TABLE 18: CLINICALLY SUSPECTED MASSES IN RECURRENT CASES 
RECURRENT CASES (N=44) 
CLINICALLY SUSPECTED MASS NO OF PATIENTS PERCENTAGE 
PRESENT 30 68% 
ABSENT 8 18% 
NOT ASSESSED 6 14% 
 
FIGURE 18: 
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TABLE 19: CLINICALLY SUSPECTED MASS WITH MRI CORRELATION 
IN RECURRENT CASES 
 
MRI FINDINGS 
CLINICALLY SUSPECTED MASS PRESENT ABSENT 
PRESENT 16 14 
ABSENT 2 6 
NOT ASSESSED 4 2 
 
FIGURE 19: 
 
 
 
1
6
 
2
 
4
 
1
4
 
6
 
2
 
P R E S E N T  A B S E N T  N O T  A S S E S E D  
MRI FINDINGS VS CLINICAL MASS 
PRESENT ABSENT
73 
 
TABLE 20: PRE TREATMENT HISTOPATHOLOGICAL TYPES IN 
RECURRENT CASES 
 
HISTOPATHOLOGY NO OF PATIENTS PERCENTAGE 
SQUAMOUS CELL CARCINOMA 41 93% 
ADENOCARCINOMA 3 7% 
 
FIGURE 20: 
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TABLE 21: LYMPH NODE INVOLVEMENT IN RECURRENT CASES 
 
LYMPH NODES NO OF PATIENTS PERCENTAGE 
ILIAC 5 15% 
PARAMETRIAL 3 9% 
INGUINAL 2 6% 
OBTURATOR 2 6% 
PARAAORTIC 1 3% 
 
FIGURE 21: 
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TABLE 22: MRI FINDINGS IN VARIOUS SEQUENCES 
 
FINDINGS PRESENT NO OF PATIENTS 
T2W 24 
DWI 22 
CONTRAST 18 
 
 
FIGURE 22: 
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TABLE 23: INVOLVEMENT OF PRIMARY AND SECONDARY NODES 
  NODE INVOLVEMENT 
CASES PRIMARY SECONDARY TOTAL 
NEW 6 3 9 
RECURRENT 5 4 9 
 
FIGURE 23 
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TABLE 24: CORRELATION OF UTERINE BODY INVOLVEMENT WITH 
MRI STAGING 
UTERINE BODY INVOLVEMENT 
MRI STAGING NO OF PATIENTS PERCENTAGE 
IB 2 7% 
IIB 9 32% 
IIIA 1 4% 
IVA 13 46% 
IVB 3 11% 
 
FIGURE 24: 
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TABLE 25: CORRELATION BETWEEN UTERINE BODY INVOLVEMENT 
AND LYMPH NODES 
UTERINE BODY INVOLVEMENT 
LYMPH NODE NEW RECURRENT 
PRIMARY 5 2 
SECONDARY 1 2 
MANN WHITNEY TEST 
P VALUE- 0.025 
SIGNIFICANT 
 
FIGURE 25: 
 
 
 
5
 
2
 
1
 
2
 
N E W  R E C U R R E N T  
LYMPH NODE IN UB INVOLVEMENT 
PRIMARY SECONDARY
79 
 
TABLE 26: CORRELATION BETWEEN MEAN SIZE OF TUMOUR AND 
STAGING 
 
NEW CASES MRI STAGING MEAN SIZE OF TUMOR        
(in cm) 
IB 2.96 
IIA 1.6 
IIB 4.85 
IVA 5.06 
IVB 6.86 
 
FIGURE 26: 
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TABLE 27: CORRELATION BETWEEN MEAN SIZE OF TUMOR AND 
NODAL INVOLVEMENT 
 
NODAL INVOLVEMENT MEAN SIZE OF TUMOR 
PRESENT 5.67 
ABSENT 4.57 
 
 
 
FIGURE 27: 
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TABLE 28: CORRELATION BETWEEN POST RT COMPLICATION AND 
MEAN DURATION AFTER RT 
 
POST RADIATION COMPLICATIONS MEAN DURATION AFTER RT 
PRESENT 3.11 
ABSENT 2.13 
 
FIGURE 28: 
 
 
  
3.11 
2.13 
0
0.5
1
1.5
2
2.5
3
3.5
PRESENT ABSENT
MEAN DURATION AFTER RT VS 
COMPLICATIONS 
82 
 
TABLE 29: POST RADIATION COMPLICATIONS 
POST RADIATION 
COMPLICATION 
NO OF CASES PERCENTAGE 
BONE MARROW CHANGES 8 20.5% 
CYSTITIS 8 20.5% 
PROCTITIS 8 20.5% 
PELVIC LIPOMATOSIS 2 5% 
FREE FLUID 2 5% 
VESICO VAGINAL FISTULA 1 2.5% 
URETERIC STRICTURE 1 2.5% 
PYOSALPHINX 1 2.5% 
 
FIGURE 29: 
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TABLE 30: OVERALL EFFICIENCY OF MRI SEQUENCES 
FINDINGS PRESENT NEW(N=26) RECURRENT(N=44) 
T2W 25 25 
DWI 25 22 
CONTRAST 23 18 
T2W+DWI 24 21 
T2W+CONTRAST 23 17 
 
TABLE 31: CORRELATION BETWEEN CLINICAL AND MRI STAGING IN 
NEW CASES 
NEWLY 
DIAGNOSED 
MRI STAGING 
CLINICAL 
STAGING LOWER 
STAGING CORRELATED 
HIGHER 
STAGING 
1A 1 0 1 
1B 0 0 1 
IIA 1 0 2 
IIB 2 7 1 
III 3 0 6 
IV 0 1 0 
TOTAL 7 8 11 
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TABLE 32: COMPARISON BETWEEN CLINICAL ASSESSMENT AND MRI 
 
CLINICAL ASSESMENT VS MRI NEW  RECURRENT 
SENSITIVITY 88% 88.89% 
SPECIFICITY 0% 30% 
POSITIVE PREDICTIVE VALUE 92.59% 53.33% 
NEGATIVE PREDICTIVE VALUE 95.65% 75% 
ACCURACY 88.19% 57.89% 
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RESULTS 
A total of 70 patients who are biopsy proven cases of carcinoma cervix are 
included in the study. Both newly diagnosed and patients treated with chemo 
radiotherapy are included. FIGO stage is assigned both clinically and with MRI 
and the parameters are compared. 
Categories of patients: 
 Two categories of patients are considered for study- 26 newly diagnosed 
patients (37% of study population) and 44 treated cases (63% of study 
population). (Table 1, Figure 1) 
 The most common presenting symptom is white discharge according to 
our study (seen in 57% of the study population) followed by lower 
abdominal pain (seen in 53% of patients). (Table 4, Figure 4) 
Age distribution: 
 The age group of patients under study is a wide range from 35 years to 73 
years. In general, majority of the patients belonged to the age group of 
41- 50 years (38% of study population) followed by 51-60 years (31% of 
the population). 6 patients belonged to less than 40 years of age. Among 
the new cases diagnosed, majority of them belonged to age more than 60. 
But, among the recurrent cases, the common age group is 41- 50 years. 
(Table 2,3 , Figure 2,3) 
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Common histopathological type: 
 The most common histopathological type was squamous cell carcinoma 
which was seen in 92% of the newly diagnosed cases and the remaining 
8% is constituted by adenocarcinoma. Squamous cell carcinoma is the 
most common histological subtype in post treatment cases also (in 41 
patients). Adenocarcinoma was seen in 3 patients. (Table 14,20 , Figure 
14,20) 
Menstrual status: 
 In our study, majority of the patients (40 in number, 57%) belonged to 
post menopausal age group. 21 patients (30%) belonged to the 
premenopausal age group. (Table 5, Figure 5) 
Comparison of surgical findings with MRI: 
 9 patients were post hysterectomy cases. Among them, 4 cases underwent 
hysterectomy for benign causes and postoperatively, histopathologic 
reports revealed carcinoma cervix. None of them had preoperative MRI. 
One patient underwent surgery for CIN III and was proven to be stage 
IIA postoperatively. One patient was diagnosed with early stage disease 
and underwent hysterectomy and was staged postoperatively as IIB. MRI 
also showed parametrial invasion at the end of 6 months of radiotherapy. 
This patient had no preoperative MRI. One patient had carcinoma ovary 
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coexisting with carcinoma cervix. Post surgically, a carcinoma of cervix 
stage IB was diagnosed. MRI also showed mass lesion involving cervix 
in this case. Two patients underwent hysterectomy before 4 years and 
now are diagnosed with vault recurrence. Among these two, only one 
patient clinically showed mass and the other was diagnosed with MRI.  
Timing of imaging after radiotherapy: 
 Radiotherapy was given for 39 patients totally and most of them (13 
patients, 33%) were symptomatic and referred for MRI during the period 
of 1- 5 years followed by less than 6 months and during the period of 6- 
12 months. (Table 6, Figure 6) 
Clinical vs MRI staging in new cases: 
 In our study, totally there are 26 biopsy proven new cases. Clinically, 
mass was identified in 23 cases (88%) and was not diagnosed for 3 cases. 
However, MRI showed the presence of mass in 25 cases. One case was 
not diagnosed both clinically and with MRI since the patient had 
underwent hysterectomy for a benign cause and was postoperatively 
diagnosed as carcinoma of cervix. MRI showed no residual lesion in this 
case. The accuracy, sensitivity, positive and negative predictive values 
of MRI in newly diagnosed cases are 88.19%, 88%, 92.59% and 
95.65% respectively. (Table 9,10,32 , Figure 9,10,32) 
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 For all the newly diagnosed cases staged with FIGO system using clinical 
examination and MRI, correlation was the best for stage II B disease and 
higher staging was given with MRI to clinical stage III disease. MRI 
staging correlated with clinical staging in 31% of new cases and there 
was up staging with MRI for 42% of cases and down staging for 27% of 
cases. (Table 11,17,31 , Figure 11,17,31) 
Identification of adjacent organ invasion: 
 In our study, significantly, 8 cases which were diagnosed as stage IIIB 
clinically were found to be stage IV A with MRI. Two cases of clinically 
staged IIA were actually found to have bladder invasion on MRI and 
hence staged as IV A. Cystoscopy showed bladder invasion in 4 cases. 
However, on MRI, 9 cases were diagnosed. One patient had both 
carcinoma of rectum and cervix. Apart from this one more case was 
identified with rectal infiltration in sigmoidoscopy. However, MRI 
showed 3 cases with rectal infiltration. (Table 12,13 , Figure 12,13) 
Identification of lymph node metastasis in new cases: 
 In our study, primary group of lymph nodes (parametrial, obturator, 
external and internal iliac nodes) was involved in 6 patients among the 
newly diagnosed. Secondary group of lymph nodes was involved in 3 
patients. One patient showed paraaortic node and the other two showed 
common iliac nodes. (Table 15,23 , Figure 15,23) 
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Efficacy of various MRI sequences in new cases: 
 In our study, among the 26 newly diagnosed cases (biopsy proven), T2 
W, DWI and contrast enhanced imaging showed lesions in 24, 25 and 23 
cases respectively. One case did not show T2 hyperintensity or contrast 
enhancement. However, the cervix appeared bulky with heterogenous 
signal. One case did not undergo contrast study and showed normal T2 
signal intensity but showed diffusion restriction. In another case the 
tumour showed poor enhancement but T2 hyperintense signal and 
diffusion restriction were noted. Thus, DWI- MRI was able to diagnose 
96% of cases and T2 W and contrast images detected 92% cases.  A 
combination of T2 W and DWI detected lesion in 24 cases. Whereas the 
one case showing only diffusion restriction needed confirmation with 
biopsy. A combination of T2 W and contrast imaging diagnosed 23 cases 
while missing 2 cases. The accuracy, sensitivity, positive and negative 
predictive values of MRI in newly diagnosed cases are 88.19%, 88%, 
92.59% and 95.65% respectively. 
         (Table 16,30 , Figure 16,30) 
Clinical staging vs MRI staging in recurrent cases: 
 In our study considering the 44 post treatment cases, clinically mass was 
suspected in 30 patients (68% cases). But MRI showed the presence of 
mass lesion in only 16 patients. Eight patients were referred for routine 
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follow up and they had no clinically identifiable mass lesion. Among 
these 8 patients, two showed lesion on MRI. In another 6 patients, cervix 
couldn’t be clinically examined due to practical difficulties. Among these 
6 patients, four showed presence of mass lesion. The accuracy, 
sensitivity, specificity, positive and negative predictive values of MRI in 
recurrent cases are 57.89%, 88.89%, 30%, 53.33% and 75% respectively. 
(Table 18,19,32 , Figure 18,19,32) 
Identification of nodal metastasis in recurrent cases: 
 In the post treatment cases, primary group of nodes was involved in 5 
patients and secondary group in 4 patients. Among the patients with 
secondary nodes involvement, inguinal nodes were involved in 2 patients, 
paraaortic nodes in one patient and common iliac nodes in 2 patients. 
(Table 21,23 , Figure 21,23) 
Efficacy of various MRI sequences in post treatment cases: 
In our study, altogether 22 patients showed lesion on MRI. All cases showing 
diffusion restriction on MRI were diagnosed as recurrent lesions. (50) So, the 
number of patients showing lesions on T2 W, DWI, and contrast studies are 24, 
22 and 18 respectively. 4 patients showed T2 hyperintensity and diffusion 
restriction in cervix. However, on contrast study, there was poor enhancement 
of the tumour in these cases. Three patients showed T2 shine through effect on 
post radiation therapy MRI. They were imaged after 1 week, 3 months and one 
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year of radiotherapy but no diffusion restriction was noted. Another patient who 
came for routine follow up and had no clinical features of recurrence showed 
mild enhancement of cervix on contrast. However, no lesion was detected on T2 
W or diffusion weighted images. In one case, imaging was done 2 months after 
radiotherapy to assess the residual tumour which was clinically suspected. MRI 
of the patient showed no obvious lesion in T2 W images whereas diffusion 
restriction was noted with early arterial phase enhancement in dynamic contrast 
studies. Thus, a diagnosis of residual tumour was made for the patient. A 
combination of T2 W imaging and DWI is able to diagnose all the 22 cases and 
also excludes the 2 false positive cases in T2 W imaging. A combination of T2 
W imaging and contrast study failed to diagnose 4 lesions showing diffusion 
restriction. (Table 22,30 , Figure 22,30) 
 Hydroureteronephrosis is an indirect sign of pelvic side wall invasion 
and was noted in 10 patients (14%). (Table 7, Figure 7) 
 According to our study, the average time of disease free survival after 
therapy was about 2.5 years. 
Assessment of prognostic indicators using MRI: 
 One of the important prognostic indicators is the uterine body 
involvement in patients with carcinoma cervix. Of the total 70 cases, 
uterine body involvement by the tumour was noted in 28 patients (37%). 
More number of cases with stage IV disease are found to have uterine 
body involvement in our study. 57% of patients with uterine body 
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involvement belong to stage IV disease. Only 2 cases with stage IB 
disease and 9 cases with stage IIB disease showed involvement of lower 
uterine body. (Table 24, Figure 24) 
 In our study, among the 28 cases with uterine body involvement, 7 
patients showed primary lymph node metastasis and 3 patients showed 
secondary lymph nodal metastasis. (Table 25, Figure 25) 
 Mean size of the tumour is another important prognostic factor. The mean 
size of tumour in patients with stage IIB, IV A and IV B are 4.85 cm, 
5.06 cm and 6.86 cm respectively. It is also noted that there is nodal 
involvement if the mean size of the tumor crosses 5.67 cm and it is not 
seen in cases where the mean size of the tumor is 4.57 cm or lesser. 
(Table 26,27 , Figure 26,27) 
Correlation of hydrometra with mass lesion: 
 In our study, hydrometra was present in 29 cases (41%). Among these, 14 
cases were newly diagnosed and 15 patients were post treatment cases. 
Among the 15 post treatment cases, 10 patients had demonstrable mass 
lesion on MRI. (Table 8 , Figure 8) 
Timing of post radiation complications: 
 From our study, it is evident that post radiation complications are more 
common to develop after 2-3 years of radiotherapy. The most common 
post radiotherapy changes are fatty replacement of bone marrow followed 
by cystitis and proctitis. (Table 28,29 , Figure 28,29) 
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REPRESENTATIVE IMAGES 
1) 46 year old patient with lesion in cervix, uterine body and upper vagina. 
Lesion showed parametrial infiltration and bladder infiltration with 
enlarged iliac and obturator nodes.  
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2) A 56 year old patient with previous history of carcinoma rectum and anal 
canal treated. Now, cervix shows a large mass with parametrial invasion 
and involvement of lower uterine body and upper vagina. Rectum also 
shows circumferential thickening with perirectal and presacral nodes. 
 
 
 
 
 
 
 
 
 
3) A 65 year old female, a known case of carcinoma cervix post 
radiotherapy now presented with white discharge. Clinically recurrence is 
suspected. MRI showed bulky cervix with altered signal. No area of 
diffusion restriction was noted. Contrast showed no abnormal 
enhancement. A case of post radiation fibrosis. 
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4) A 57 year old patient with previous history of hysterectomy. MRI showed 
vault recurrence with infiltration of vulva, urethra and left ischioanal 
fossa. 
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5) A 44 year old female with large mass lesion in cervix showing contrast 
enhancement. There is extension into parametrium, vagina, lower uterine 
body with luminal extension into rectum. 
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6) A 70 year old female with growth in cervix extending to lower uterine 
body and upper vagina and also showed bladder infiltration. 
 
Paraaortic nodal involvement and extension of the growth to both ovaries 
showing solid cystic areas. 
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DISCUSSION 
 Two categories of patients are considered for study- 26 newly diagnosed 
patients (37% of study population) and 44 treated cases (63% of study 
population). 
 The most common presenting symptom is white discharge according 
to our study (seen in 57% of the study population) followed by lower 
abdominal pain (seen in 53% of patients). 
 Among the new cases diagnosed, majority of them belonged to age more 
than 60. But, among the recurrent cases, the common age group is 41- 50 
years. These patients must have been diagnosed with disease at an early 
age. Thus, it is seen that when the life expectancy is more, the 
possibility of recurrence of tumor is also more. 
 The most common histopathological type was squamous cell 
carcinoma in both newly diagnosed and recurrent cases. 
 In our study, majority of the patients belonged to post menopausal age 
group. Thus, the disease is more prevalent among post menopausal 
women.  
 According to our study, the average time of disease free survival after 
therapy was about 2.5 years. 
 In our study, totally there are 26 biopsy proven new cases. Clinically 
mass was identified in 23 cases and was not diagnosed for 3 cases. 
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However, MRI showed the presence of mass in 25 cases. It was also 
noted that accurate staging was lacking in cases who underwent 
hysterectomy for early stage disease and for benign reasons. These 
patients would be benefitted with MRI. The accuracy, sensitivity, 
positive and negative predictive values of MRI in newly diagnosed 
cases are 88.19%, 88%, 92.59% and 95.65% respectively. 
 MRI without contrast is reliable in assessing the parametrium and 
pelvic side wall invasion. T2 W images give good information. This is in 
agreement with the study by Freeman SJ et al., and Hawighorst et al., 
(47,48) 
 MRI scores better in delineating the invasion of adjacent organs. In 
our study, significantly, 8 cases which were diagnosed as stage IIIB 
clinically were found to be stage IV A with MRI. Two cases of clinically 
staged IIA were actually found to have bladder invasion on MRI and 
hence staged as IV A. MRI evaluation prevented unnecessary surgical 
intervention in these patients. Invasion of bladder and rectum can be 
ruled out with sufficient confidence with MRI. This is in accordance 
with the previous study done by Kim et al. (44) 
 For all the newly diagnosed cases staged with FIGO system using clinical 
examination and MRI, correlation was the best for stage II B disease 
and higher staging was given with MRI to clinical stage III disease. 
MRI staging correlated with clinical staging in 31% of new cases and 
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there was up staging with MRI for 42% of cases and down staging for 
27% of cases. This was due to the reason that all the stage III disease 
patients diagnosed clinically had minimal bladder wall/ rectal wall 
invasion which was missed and the cases were misclassified. So MRI is 
advocated in all advanced cases for proper staging and prognostication.  
 From our study, it is evident that there is no definite role for contrast 
study in all the cases which are newly evaluated. There is no added 
advantage of contrast over plain study. DWI- MRI was able to diagnose 
96% of cases and T2 W and contrast images detected 92% cases. Among 
the 26 newly diagnosed cases (biopsy proven), T2 W, DWI and contrast 
enhanced imaging showed lesions in 24, 25 and 23 cases respectively. A 
combination of T2 W and DWI detects lesion in 24 cases. A combination 
of T2 W and contrast imaging diagnosed 23 cases and missed 2 cases. 
This is in concordance with the studies done by Hawighorst et al., and 
Schiedler J et al., who found that no value is added by this sequence. (46). 
This finding is also in concordance with the study by Lucas et al., who 
reported a higher accuracy for the combination of T2 WI and DWI in the 
diagnosis of the lesion.  
 In our study, primary group of lymph nodes (parametrial, obturator, 
external and internal iliac nodes) was involved in 6 patients (23%) among 
the newly diagnosed. Secondary group of lymph nodes was involved in 3 
patients. (11.5%). This is lower than that reported by Drescher et al in his 
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study. This may be because his study included more number of patients 
with histology of adenocarcinoma. (45) 
 From our study involving post treatment cases, it is clearly evident that 
there is no added value of routine contrast imaging for all post 
radiotherapy cases. It has an added value in case of discrepancies 
between findings inT2 W imaging and DWI where it serves as a problem 
solving tool. In our study, altogether 22 patients showed lesion on MRI. 
The number of patients showing lesions on T2 W, DWI, and contrast 
studies are 24, 22 and 18 respectively. A combination of T2 W imaging 
and DWI is able to diagnose all the 22 cases and also excludes the 2 false 
positive cases in T2 W imaging. Kinkel et al., in his work found that in 
the first five months after radiotherapy, inflammatory changes may be 
responsible for the early enhancement that may mimic recurrence. (49). 
This finding is in concordance with the study by Lucas et al., who 
reported a higher accuracy for the combination of T2 WI and DWI in the 
diagnosis of the lesion.  
 In our study, MRI helped to exclude the patients with no recurrence of 
tumour or no residual mass in post treatment phase so that over treatment 
of these cases with radiotherapy could be avoided. It also aided in the 
diagnosis of recurrence in 6 cases which were clinically undiagnosed so 
that appropriate treatment could be instituted in these cases. One of the 
patients had pure nodal recurrence with no pelvic mass and MRI helped 
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in the diagnosis. The accuracy, sensitivity, specificity, positive and 
negative predictive values of MRI in recurrent cases are 57.89%, 
88.89%, 30%, 53.33% and 75% respectively. 
 In the post treatment cases, primary group of nodes was involved in 5 
patients and secondary group in 4 patients.  
 The most important prognostic indicators are size of the tumor, 
uterine body involvement by the tumor and nodal metastasis. 
 More number of cases with stage IV disease are found to have uterine 
body involvement in our study. Thus, uterine body involvement could 
be directly correlated with advanced stage of the disease. In our study, 
the uterine body involvement could be positively correlated with 
lymph nodal metastasis with a significant “p value” of 0.025. Thus, 
among the 28 cases with uterine body involvement, 7 patients showed 
primary lymph node metastasis and 3 patients showed secondary lymph 
nodal metastasis. 
 Mean size of the tumor is another important prognostic factor as this 
could be correlated with the stage of the disease and nodal involvement. 
The mean size of the tumor correlates well with tumor staging in 
stages greater than IIA. It is also noted that there is nodal involvement 
if the mean size of the tumor crosses 5.67 cm. 
 In one third of post treatment patients, the hydrometra is due to cervical 
stenosis, a complication of radiation therapy. 
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 From our study, it is evident that post radiation complications are more 
common to develop after 2-3 years of radiotherapy which also 
corresponds with the average time of recurrence. Since most of the 
patients are referred during this time to look for recurrence of tumor, 
more complications are also diagnosed during this time. The most 
common post radiotherapy changes are fatty replacement of bone 
marrow followed by cystitis and proctitis. 
 
 
 
  
104 
 
CONCLUSION 
       Usefulness of MRI staging in 70 patients of biopsy proven cases of 
carcinoma cervix were assessed in the study. Both newly diagnosed and patients 
treated with chemo radiotherapy were included. FIGO stage was assigned both 
clinically and with MRI and the parameters were compared. 26 newly 
diagnosed patients and 44 treated cases were included. The most common 
presenting symptom was white discharge according to our study followed by 
lower abdominal pain. Majority of the patients belonged to the age group of 41- 
50 years  followed by 51-60 years  Among the new cases diagnosed, majority of 
them belonged to age more than 60years, that is, post menopausal age was more 
vulnerable for carcinoma cervix. But, among the recurrent cases, the common 
age group was 41- 50 years. Thus, it was inferred that when the life expectancy 
was more, the possibility of recurrence of tumor was also more. We found in 
our study that the average time of disease free survival after therapy was about 
2.5 years. The most common histopathological type in both newly diagnosed 
cases and post treatment cases was squamous cell carcinoma and the remaining 
was constituted by adenocarcinoma.  
         In our study, totally there were 26 biopsy proven new cases.  However, 
MRI proved the best in identifying mass better than clinical identification.  The 
accuracy, sensitivity, positive and negative predictive values of MRI in newly 
diagnosed cases are 88.19%, 88%, 92.59% and 95.65% respectively. In our 
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study, we proved that MRI scored better in delineating the invasion of adjacent 
organs. MRI can replace cystoscopy and sigmoidoscopy in identifying bladder 
and rectal wall invasion. 
         A combination of T2 W imaging and Diffusion Weighted imaging would 
be the optimal technique for imaging both new and post treatment cases. T2 and 
Diffusion weighted images were the best sequences not only in identifying 
recurrence but also in excluding false positive in already treated patients. 
Contrast study provides no additional information was inferred from our study. 
For all the newly diagnosed cases staged with FIGO system using MRI, 
correlation was the best for stage II B disease and higher staging was given with 
MRI to clinical stage III disease. MRI staging correlated with clinical staging in 
31% of new cases and there was up-staging with MRI for 42% of cases and 
down-staging for 27% of cases.  
        The most important prognostic indicator was the uterine body involvement 
in patients with carcinoma cervix. Uterine body involvement could be directly 
correlated with advanced stage of the disease and it is also associated with nodal 
metastases. Among the post treatment cases, hydrometra was more commonly 
associated with cervical mass. Only a few showed cervical stenosis. Nodal 
involvement is another important prognostic factor. Both in new and post 
treatment cases, primary group of nodes was more commonly involved than 
secondary group. Mean size of the tumor was another important prognostic 
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factor as this could be correlated with the stage of the disease and nodal 
involvement. The mean size of the tumor correlated well with tumor staging in 
stages greater than IIA.  It was noted that there was nodal involvement if the 
mean size of the tumor crossed 5.67 cm and it was not seen in cases where the 
mean size of the tumor was 4.57 cm or lesser. 
        From our study, it was evident that post radiation complications were more 
common to develop after 2-3 years of radiotherapy which also corresponded 
with the average time of recurrence. The most common post radiotherapy 
changes were fatty replacement of bone marrow followed by cystitis and 
proctitis. 
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SUMMARY 
To summarize, when MRI was compared with clinical FIGO 
staging of carcinoma cervix, mass was easily identified by MRI. MRI 
staging correlated well with clinical staging in II B. Hence, it greatly 
helps in deciding treatment. MRI can be used as a single best 
investigation in the staging obviating the need for multiple invasive 
procedures. Clinical stage III was frequently up-staged using MR 
imaging. A combination of T2 and DWI was the optimum technique in 
both new and recurrent cases. Invasion of parametrium, pelvic side wall 
and adjacent organs are depicted clearly in MRI. Nodal status was also 
assessed using these sequences. Primary nodal involvement was 
commoner than paraaortic lymphadenopathy. Size of mass lesion, uterine 
body involvement and nodal metastasis were important prognostic factors 
that could be correlated with the stage of disease and these were assessed 
better using MRI. Uterine body involvement was an important prognostic 
factor as it was associated with stage IV disease and nodal metastases. 
Complications of radio therapy were also better evaluated using MRI.  
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PROFORMA 
 
 NAME OF THE PATIENT: 
 AGE OF THE PATIENT: 
 NEWLY DIAGNOSED/ PREVIOUS TREATMENT : 
 
 P/V FINDINGS: 
 
 
 OTHER INVESTIGATIONS: 
 
 
 
 
 FIGO STAGING: 
 
 MRI FINDINGS: 
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CONSENT FORM 
Yourself Mr/ Mrs.............................................. are being asked to be a 
participant in the research study titled “ROLE OF MR IMAGING ON 
DIAGNOSIS, STAGING AND FOLLOW UP OF PATIENTS WITH 
CARCINOMA CERVIX” in Coimbatore Medical College hospital, 
Coimbatore, conducted by Dr. C. KALAI VANI, post graduate student in the 
Department of Radiology, Coimbatore Medical College Hospital. You satisfy 
eligibility as per the inclusion criteria. You can ask any questions you may have 
before agreeing to participate. 
PURPOSE OF STUDY 
 To evaluate the efficacy of MRI in assessment of important prognostic 
factors in carcinoma cervix like tumour size , involvement of 
parametrium , involvement of pelvic side wall , involvement of adjacent 
organs and the nodal status and how it alters the plan of management . 
 To study the role of MRI in detecting the recurrence of carcinoma cervix 
in patients treated with radiotherapy. 
 To correlate MRI findings with FIGO staging of carcinoma cervix. 
 To evaluate the validity of MRI in detection of treatment response and 
recurrence in treated patients of carcinoma cervix. 
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PROCEDURES INVOLVED: 
 Non contrast and contrast MRI sequences  are performed. The contrast 
used is 0.1mmol/kg of Gadolinium DTPA. 
 
PRIVACY AND CONFIDENTIALITY 
Privacy of individuals will be respected and any information provided 
will be kept confidential. 
 
AUTHORIZATION TO PUBLISH RESULTS 
Results of the study may be published for scientific purposes and / or 
presented to scientific groups; however you will not be identified. 
STATEMENT OF CONSENT 
I volunteer and consent to participate in this study. I have read the 
consent or it has been read to me. The study has been fully explained to 
me and I may ask questions at any time. 
...................................................................................................................... 
Signature/ left thumb impression of volunteer with date 
...................................................................................................................... 
Signature of witness with date 
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